ICD-10: | L73.0 |
---|---|
Short Description: | Acne keloid |
Long Description: | Acne keloid |
Oct 01, 2021 · L73.0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM L73.0 became effective on October 1, 2021. This is the American ICD-10-CM version of L73.0 - other international versions of ICD-10 L73.0 may differ.
ICD-10-CM Code L73.0Acne keloid. ICD-10-CM Code. L73.0. BILLABLE. Billable Code. Billable codes are sufficient justification for admission to an acute care hospital when used a principal …
L73.0 is a billable diagnosis code used to specify a medical diagnosis of acne keloid. The code L73.0 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 …
Histology of folliculitis keloidalis. Categories: Pathology, Follicular disorder. Subcategories: Neutrophilic scarring alopecia, Cicatricial alopecia. ICD-10: L73.0. ICD-11: EE60.Y.
CPT | |
---|---|
L91.0 | Hypertrophic scar (keloid) |
Hypertrophic Scars Versus Keloids | |
---|---|
Hypertrophic Scars Versus Keloids | |
Appearance around wound | Stays within wound area |
Color | Pink to red |
Where found on body | More common in taut skin areas |
Acne keloidalis nuchae (also known as "Acne keloidalis", "Dermatitis papillaris capillitii", "Folliculitis keloidalis", "Folliculitis keloidis nuchae", and "Nuchal keloid acne":526) is a destructive scarring folliculitis that occurs almost exclusively on the occipital scalp of people of African descent, primarily men.
The ICD-10-CM Alphabetical Index links the below-listed medical terms to the ICD code L73.0. Click on any term below to browse the alphabetical index.
This is the official approximate match mapping between ICD9 and ICD10, as provided by the General Equivalency mapping crosswalk. This means that while there is no exact mapping between this ICD10 code L73.0 and a single ICD9 code, 706.1 is an approximate match for comparison and conversion purposes.
L73.0 is a billable diagnosis code used to specify a medical diagnosis of acne keloid. The code L73.0 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.
ACNE KELOID-. a type of acneiform disorder in which secondary pyogenic infection in and around pilosebaceous structures end s in keloidal scarring. it manifests as persistent folliculitis of the back of the neck associated with occlusion of the follicular orifices. it is most often encountered in black or asian men.
The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code L73.0 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.
Acne. Also called: Pimples, Zits. Acne is a common skin disease that causes pimples. Pimples form when hair follicles under your skin clog up. Most pimples form on the face, neck, back, chest, and shoulders. Anyone can get acne, but it is common in teenagers and young adults. It is not serious, but it can cause scars.
Most pimples form on the face, neck, back, chest, and shoulders. Anyone can get acne, but it is common in teenagers and young adults. It is not serious, but it can cause scars.
Most pimples form on the face, neck, back, chest, and shoulders. Anyone can get acne, but it is common in teenagers and young adults. It is not serious, but it can cause scars. No one knows exactly what causes acne. Hormone changes, such as those during the teenage years and pregnancy, probably play a role.
Anyone can get acne, but it is common in teenagers and young adults. It is not serious, but it can cause scars. No one knows exactly what causes acne. Hormone changes, such as those during the teenage years and pregnancy, probably play a role. There are many myths about what causes acne.
Folliculitis keloidalis (also called folliculitis keloidalis nuchae) is best grouped as one of the neutrophilic scarring alopecias.
Low power view exhibits a dense superficial and deep inflammatory process with dermal scarring and follicular disruption (Figure 1). There may be variable degrees of overlying scale crust with tufted hair follicles evident as multiple hair shafts within widened follicular infundibulae (Figures 1 and 2).
PAS staining should always be performed to exclude a fungal infection.
Folliculitis decalvans: While many features are shared, there is typically significantly less fibrosis in this condition. Clinical discrimination is reliable.
Acne keloidalis nuchae (AKN), or folliculitis keloidalis, is a chronic inflammatory disease in which pustules and keloid-like papules and plaques occur at the nape of the neck, occipital scalp, and sometimes extend up to the vertex scalp.
Acne keloidalis nuchae (AKN), or folliculitis keloidalis, is a chronic inflammatory disease in which pustules and keloid-like papules and plaques occur at the nape of the neck, occipital scalp, and sometimes extend up to the vertex scalp. Despite its name, it is generally accepted that the lesion is not associated with acne, is not a true keloid, and can occur beyond the nuchal area.
AKN has been reported in other racial / ethnic groups, including individuals of Hispanic and Korean descent and White people. Women are rarely affected unless they shave their hair at the nape of the neck. AKN is rare in patients before puberty or after age 50. The condition is often painful and disfiguring.
The condition is often painful and disfiguring. Inflammation of the hair follicle and fibrosis of the tissue typically result in scarring, including scarring alopecia. The etiology is unclear; many different hypotheses and factors have been proposed.
Tinea capitis (and its complication, a kerion ) – A dermatophyte infection commonly seen in children. Folliculitis – May affect other hair-bearing areas of the body. Dissecting cellulitis of the scalp – Frequently involves the vertex in addition to the occiput.
Acne keloidalis nuchae (also known as "acne keloidalis", "dermatitis papillaris capillitii", "folliculitis keloidalis", "folliculitis keloidis nuchae", and "nuchal keloid acne") is a destructive scarring folliculitis that occurs almost exclusively on the occipital scalp of people of African descent, primarily men.
Acne keloidalis nuchae most commonly presents itself in individuals aged 13 to 25. The disease is closely related to pseudofolliculitis barbae and both occur frequently in black men in the military, where it is so common that the US Army has developed official protocols for management.
AKN is characterized by firm pink or flesh-colored hyperpigmented bumps in the skin, which are usually located on the back of the back of the neck. This is mainly because men often cut their hair very low as opposed to women, allowing the hair to prick the occipital scalp thereby causing irritation.
Bacterial folliculitis and acne can mimic the appearance of AKN; however, unlike acne, comedones are not seen with AKN. Treatments for AKN aim to reduce inflammation and prevent infections and scarring.
Therapies for AKN may include topical antibiotics, topical or intralesional corticosteroids, and laser hair removal. Recommended modifications to shaving habits include liberal use of shaving cream, avoidance of stretching the skin while shaving, and use of a single-blade razor rather than a razor with multiple blades.
Folliculitis keloidalis is more common in dark-skinned people than in whites and most often affects adult Afro-Caribbean males with black curly hair. It is 20 times more common in males than in females.
Some researchers have concluded that folliculitis keloidalis may begin with an injury during a close hair cut or the use of a razor. It is thought to be a mechanical form of folliculitis, in which ingrown hair shafts irritate the wall of the hair follicle resulting in inflammation.
Others argue that folliculitis keloidalis is a primary skin disease unrelated to either ingrown hairs or bacterial infection. An association of folliculitis keloidalis with obesity and metabolic syndrome has been observed in some patients.
Others argue that folliculitis keloidalis is a primary skin disease unrelated to either ingrown hairs or bacterial infection. An association of folliculitis keloidalis with obesity and metabolic syndrome has been observed in some patients.
Folliculitis keloidalis is an unusual form of chronic folliculitis ( inflammation of hair follicle unit) and cicatricial alopecia (scarring hair loss) that affects the nape of the neck. Folliculitis keloidalis, or folliculitis keloidalis nuchae, is sometimes called acne cheloidalis nuchae or acne keloidalis.
Sometimes there are pustules around the hair follicles ( folliculitis ). As time goes on the bumps become small scars and then the small scars may greatly enlarge to become keloid-like masses. The scars are hairless and can form a band along the hairline.
As time goes on the bumps become small scars and then the small scars may greatly enlarge to become keloid-like masses. The scars are hairless and can form a band along the hairline. Tufted hairs may be present; these are multiple hair shafts emerging from a single follicular opening.
Aetna considers excimer and pulsed dye laser treatment medically necessary for persons with mild-to-moderate localized plaque psoriasis affecting 10 % or less of their body area who have failed to adequately respond to 3 or more months of topical treatments, including at least 3 of the following: Anthralin;
Aetna considers the excimer laser or pulsed dye laser experimental and investigation al in the treatment of forms of psoriasis other than plaque psoriasis because of insufficient evidence in the peer-reviewed literature. Aetna considers laser treatment cosmetic for the following indications (not an all-inclusive list): Pearly penile papules.
Plaque psoriasis can appear on any skin surface, although the knees, elbows, scalp, trunk and nails are the most common locations. There are several other types of psoriasis, and between 10 % and 30 % of people with psoriasis also develop psoriatic arthritis.
There is evidence from controlled clinical trials of the effectiveness of excimer laser treatment of mild-to-moderate psoriasis. However, the comparative effectiveness of topical and laser treatment of psoriasis is unknown because these treatments have not been directly compared in a prospective clinical study.